
Insider and congress filings
ResMed Inc. (RMD)
NYSE · Healthcare · 334 insider transactions · 51 congress trades · last filed 18 days agoS&P 500
About ResMed Inc.
from the company's filings and listing, as of Oct 25, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Michael J. Farrell
- Employees
- 11,370
- Listed since
- Jun 2, 1995
- Market value
- $35.6B
- Price to earnings (12 mo)
- 24.2
- Net income per share, as reported (12 mo)
- $10.53
- Dividend yield
- 0.97%
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q4 FY2026reported Aug 6, 2026 | $2.95 | $2.89 | $1.5B | $1.5B | EPS beatRevenue in line |
| Q3 FY2026reported Apr 30, 2026 | $2.86 | $2.80 | $1.4B | $1.4B | EPS beatRevenue in line |
| Q2 FY2026reported Jan 29, 2026 | $2.81 | $2.74 | $1.4B | $1.4B | EPS beatRevenue beat |
| Q1 FY2026reported Oct 30, 2025 | $2.55 | $2.51 | $1.3B | $1.3B | EPS beatRevenue in line |
| Q4 FY2025reported Jul 31, 2025 | $2.55 | $2.46 | $1.3B | $1.3B | EPS beatRevenue in line |
| Q3 FY2025reported Apr 23, 2025 | $2.37 | $2.38 | $1.3B | $1.3B | EPS in lineRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $2.4B | 12,317,194 | +1.8% | 8.51% |
| Vanguard Capital Management LLC | $1.8B | 9,474,129 | +0.1% | 6.55% |
| Vanguard Portfolio Management LLC | $1.5B | 7,913,661 | +0.6% | 5.47% |
| State Street Corp | $1.3B | 6,680,735 | +0.6% | 4.62% |
| Geode Capital Management, LLC | $845.2M | 4,352,320 | 0.0% | 3.01% |
| Bank of New York Mellon Corp | $818.0M | 4,197,610 | -14.8% | 2.90% |
| First Trust Advisors LP | $444.1M | 2,278,696 | +48.2% | 1.57% |
| Invesco Ltd. | $402.1M | 2,063,578 | +5.5% | 1.43% |
| Morgan Stanley | $375.9M | 1,928,931 | -28.2% | 1.33% |
| Northern Trust Corp | $330.6M | 1,696,674 | -1.7% | 1.17% |
| Nordea Investment Management AB | $269.6M | 1,388,008 | +34.3% | 0.96% |
| Deutsche Bank AG | $257.7M | 1,322,313 | -7.1% | 0.91% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Open-market insider trades
20 filings shown · newest filing first| Insider | Action | Shares | Price | Value | Trade date | Delay (business days) |
|---|---|---|---|---|---|---|
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $226.33 | $1.1M | Oct 7, 2026filed Oct 8, 2026 | 1d |
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $222.44 | $1.1M | Sep 8, 2026filed Sep 10, 2026 | 2d |
| Peter C. FarrellDirector | Sold · scheduled | 970 | $234.73 | $228K | Sep 2, 2026filed Sep 4, 2026 | 2d |
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $205.69 | $1.0M | Aug 7, 2026filed Aug 11, 2026 | 2d |
| Peter C. FarrellDirector | Sold · scheduled | 8,000 | $225.00 | $1.8M | Aug 5, 2026filed Aug 6, 2026 | 1d |
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $218.55 | $1.1M | Jul 7, 2026filed Jul 9, 2026 | 2d |
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $193.96 | $968K | Jun 8, 2026filed Jun 9, 2026 | 1d |
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $207.82 | $1.0M | May 7, 2026filed May 11, 2026 | 2d |
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $225.50 | $1.1M | Apr 7, 2026filed Apr 9, 2026 | 2d |
| Brett SandercockChief Financial Officer | Sold · scheduled | 1,000 | $224.31 | $224K | Apr 1, 2026filed Apr 3, 2026 | 2d |
| Peter C. FarrellDirector | Sold · scheduled | 2,000 | $225.00 | $450K | Apr 1, 2026filed Apr 2, 2026 | 1d |
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $251.03 | $1.3M | Mar 9, 2026filed Mar 11, 2026 | 2d |
| Peter C. FarrellDirector | Sold · scheduled | 2,000 | $260.22 | $520K | Mar 4, 2026filed Mar 5, 2026 | 1d |
| Brett SandercockChief Financial Officer | Sold · scheduled | 1,000 | $254.30 | $254K | Mar 2, 2026filed Mar 3, 2026 | 1d |
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $273.78 | $1.4M | Feb 9, 2026filed Feb 10, 2026 | 1d |
| Michael J. RiderGlobal General Counsel | Sold · scheduled | 50 | $260.00 | $13K | Feb 4, 2026filed Feb 6, 2026 | 2d |
| Peter C. FarrellDirector | Sold · scheduled | 2,000 | $251.31 | $503K | Feb 4, 2026filed Feb 6, 2026 | 2d |
| Brett SandercockChief Financial Officer | Sold · scheduled | 1,000 | $257.03 | $257K | Feb 2, 2026filed Feb 3, 2026 | 1d |
| Peter C. FarrellDirector | Sold · scheduled | 2,000 | $248.83 | $498K | Jan 7, 2026filed Jan 9, 2026 | 2d |
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $248.46 | $1.2M | Jan 7, 2026filed Jan 8, 2026 | 1d |
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Oct 7, 2026 |
| Justin LeongChief Product Officer | Stock award | 6,461 | Aug 14, 2026 |
| Michael J. RiderGlobal General Counsel | Stock award | 3,230 | Aug 14, 2026 |
| Michael J. FarrellChairman and CEO | Stock award | 13,547 | Aug 14, 2026 |
| Aaron BloomerChief Financial Officer | Stock award | 9,072 | Aug 14, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Sep 8, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Aug 7, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Jul 7, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Jun 8, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | May 7, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Apr 7, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Mar 9, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Feb 9, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Jan 7, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Dec 8, 2025 |
| Nicole Mowad-NassarDirector | Stock award | 1,331 | Nov 24, 2025 |
| Peter C. FarrellDirector | Stock award | 1,331 | Nov 24, 2025 |
| Michael J. FarrellChairman and CEO | Stock award | 33,288 | Nov 24, 2025 |
| Peter C. FarrellDirector | Stock award | 536 | Nov 20, 2025 |
| Jan De WitteDirector | Stock award | 1,073 | Nov 20, 2025 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Congress trades in RMD
20 disclosures of 51 on record · median 16d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 25, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +17.5%S&P 500 +0.3% · +17.2 pts vs S&P 500 | Aug 3, 2026 | Sep 4, 2026 | 32d |
| Alan ArmstrongSelf | Stock | Purchase | $1,001 - $15,000 | +14.7%S&P 500 +19.8% · -5.1 pts vs S&P 500 | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +30.4%S&P 500 +1.3% · +29.1 pts vs S&P 500 | Jun 16, 2026 | Jul 6, 2026 | 20d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +29.8%After the saleS&P 500 +1.7% · +28.0 pts vs S&P 500 | Jun 30, 2026 | Jul 6, 2026 | 6d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +23.3%S&P 500 +5.4% · +17.9 pts vs S&P 500 | May 1, 2026 | Jun 9, 2026 | 39d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +25.3%After the saleS&P 500 +2.8% · +22.4 pts vs S&P 500 | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +22.7%S&P 500 +1.3% · +21.4 pts vs S&P 500 | May 27, 2026 | Jun 9, 2026 | 13d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +9.8%S&P 500 +10.8% · -0.9 pts vs S&P 500 | Apr 13, 2026 | May 11, 2026 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +15.0%S&P 500 +6.4% · +8.6 pts vs S&P 500 | Apr 24, 2026 | May 11, 2026 | 17d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +10.9%After the saleS&P 500 +15.6% · -4.7 pts vs S&P 500 | Mar 23, 2026 | Apr 7, 2026 | 15d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +14.9%After the saleS&P 500 +20.3% · -5.3 pts vs S&P 500 | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +0.5%S&P 500 +10.5% · -10.0 pts vs S&P 500 | Feb 24, 2026 | Mar 9, 2026 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -1.8%After the saleS&P 500 +9.5% · -11.3 pts vs S&P 500 | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +0.2%After the saleS&P 500 +10.2% · -10.0 pts vs S&P 500 | Jan 23, 2026 | Feb 6, 2026 | 14d |
| Kelly Morrison | Stock | Sale | $1,001 - $15,000 | +1.2%After the saleS&P 500 +27.6% · -26.4 pts vs S&P 500 | Jun 4, 2025 | Jun 18, 2025 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +3.3%S&P 500 +29.3% · -26.0 pts vs S&P 500 | May 28, 2025 | Jun 10, 2025 | 13d |
| Kelly Morrison | Stock | Sale | $1,001 - $15,000 | +8.0%After the saleS&P 500 +37.9% · -29.9 pts vs S&P 500 | Apr 28, 2025 | May 13, 2025 | 15d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +17.9%After the saleS&P 500 +42.0% · -24.0 pts vs S&P 500 | Apr 23, 2025 | May 12, 2025 | 19d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +12.4%S&P 500 +32.6% · -20.3 pts vs S&P 500 | Mar 6, 2025 | Apr 10, 2025 | 35d |
| Robert BresnahanJoint | Stock | Sale | $1,001 - $15,000 | +9.8%After the saleS&P 500 +30.7% · -20.9 pts vs S&P 500 | Jan 13, 2025 | Feb 13, 2025 | 31d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in RMD, filterable by party, chamber, type and account.
Members of Congress reporting a position
4 members · estimate, as of Oct 24, 20264 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Robert Bresnahan | Republican · House | $15,001 - $50,000 | 0.1% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $1,001 - $15,000 | <0.1% |
| Julie Johnson | Democrat · House | $1,001 - $15,000 | 0.1% |
| Lucy McBath | Democrat · House | $1,001 - $15,000 | 0.1% |
Estimate, as of Oct 24, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Are insiders buying or selling RMD?
Across the 20 most recent open-market filings shown here, 0 were purchases and 20 were sales. 20 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded RMD?
Ro Khanna, Alan Armstrong, Kelly Morrison and Robert Bresnahan disclosed RMD transactions in the filings shown here.
Which members of Congress hold RMD?
4 members of Congress report a position in RMD in the estimate we hold as of Oct 24, 2026. The largest estimated position belongs to Robert Bresnahan; the next largest, in the $1,001 - $15,000 band, include Gilbert Ray Cisneros, Jr. and Julie Johnson. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is RMD in the S&P 500 or the Nasdaq 100?
ResMed Inc. is a current member of the S&P 500, per the membership list we hold as of Oct 26, 2026. Current members of either index get a page here whatever their filing history.
How quickly are RMD trades disclosed?
Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 16 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.
